JPRN-jRCTs041190079招募中未知
Examination of effectiveness of tissue plasminogen activator(t-PA) for central retinal artery occlusion(CRAO)
Hayashi Atsushi0 个研究点目标入组 20 人开始时间: 2019年11月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Patients older than 20
- •2.Diagnosed with central retinal artery occulusion within 24 hours
- •3.Treated with pars plana vitrectomy as an inpatient in this research facility
- •4.No history of cerebrovascular disease such as stroke,
- •and judged that drug used in this research is not deterioration factor
- •5.Obtain written informed consent
排除标准
- •1.Expected that the drug influence previous disease
- •2.central retinal artery occlusion more than 24 hours after the onset
- •3.Pregnant, possibile pregnancy or hope for pregnancy during the study period
研究者
相似试验
已完成
2 期
Effect of treatment with tissue plasminogen activator in improving clinical status of patients with acute ischemic strokeIRCT201709049014N182Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences40
招募中
3 期
The role of anticoagulant and thrombolitic in treatment of COVID patientsCOVID 19.COVID-19, virus identifiedU07.1IRCT20200515047456N1Tabriz University of Medical Sciences15
尚未招募
不适用
Comparison of Biomarker in diabetic patients with and without foot infectionsCTRI/2019/01/017176JIPMER
已完成
2 期
The effect of plasma rich in growth factors in treatment of gingival recessioGingival Recession.Gingival recession (generalized)(localized)(post infective)(post-operative)IRCT201201168747N1Vice chancellor for research, Babol University of Medical Sciences22
招募中
不适用
The assessment of the effect of plasmapheresis treatment for the management of sever COVID-19 patientsIRCT20200414047076N2Esfahan University of Medical Sciences70